| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d84dca9ba917550dae4cbbfa9f5bc15c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b68f5a771c23e9a0800e2f8b90f5e69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a040110e66078985180a553593bde1c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cea72e2de3c0219165474e54e9842d16 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| filingDate |
2005-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb8c13aae610242b6aad7d3dc0e76ae3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92a0f993d327e2758c2123fff8985ca6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_346a962764a3beab1387e9d4fde01844 |
| publicationDate |
2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005099773-A1 |
| titleOfInvention |
Use of erythropoietin for treatment of cancer |
| abstract |
A method for treating cancer is provided. The method involves administering to subjects in need of such treatment an effective amount of erythropoietin of an analog thereof effective to inhibit angiogenesis in a tumor. Also provided are methods to reduce HIF-lα protein levels and/or VEGF expression, particularly in tumors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015189813-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11078270-B2 |
| priorityDate |
2004-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |